Technology

This magazine is not receiving updates (last activity 0 day(s) ago).

BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study ( www.bluerocktx.com )

BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study::Investigational Bemdaneprocel (BRT-DA01) was well tolerated with no major safety issues in all 12 patients through one year Assessment of secondary endpoints demonstrates feasibility of transplantation...

Twitter warns it could sue Meta over “copycat” Threads app ( www.theverge.com )

Twitter is threatening to sue Meta over concerns about its new Threads app, according to a letter obtained by Semafor. In the letter, which is addressed to Meta CEO Mark Zuckerberg, Twitter lawyer Alex Spiro argues that Meta used Twitter’s trade secrets and intellectual property to build Threads....

  • All
  • Subscribed
  • Moderated
  • Favorites
  • [email protected]
  • kbinchat
  • All magazines